Case study: Participant takes part in COVID-19 vaccine study to do his bit
Will’s story: Valneva’s inactivated COVID-19 Vaccine Trial
"The pandemic has affected everyone so negatively and we all just want to get back to regular everyday life now, and I feel a key way that we're going to do this is through the vaccination programmes. So I saw the opportunity to take part in the Valneva study in Bristol and I felt like it would be a really good way to do my bit."
Phase 3 of the Valneva vaccine study opened in Bristol in April 2021.
The vaccine is the only inactivated, adjuvanted COVID-19 vaccine in clinical development in Europe.
Will is one of the volunteers taking part in the study. Watch his story of taking part in research below or read the full video transcript.